U.S. FDA Says No to Using Split Predicates in ‘Substantial Equivalence’ Applications

International Medical Device Regulatory Monitor
A A
Manufacturers are all but blocked from using split predicates for 510(k) devices, under a newly finalized U.S. Food and Drug Administration guidance on substantial equivalence determinations.

To View This Article:

Login

Subscribe To International Medical Device Regulatory Monitor

Buy This Article Now

Add this article to your cart for $40.00